Literature DB >> 18687795

Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Marie-Pierre Audrezet1, Aurélia Dabricot, Cédric Le Marechal, Claude Ferec.   

Abstract

High-resolution melting analysis of polymerase chain reaction products for mutation scanning, which began in the early 2000s, is based on monitoring of the fluorescence released during the melting of double-stranded DNA labeled with specifically developed saturation dye, such as LC-Green. We report here the validation of this method to scan 98% of the coding sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. We designed 32 pairs of primers to amplify and analyze the 27 exons of the gene. Thanks to the addition of a small GC-clamp at the 5' ends of the primers, one single melting domain and one identical annealing temperature were obtained to co-amplify all of the fragments. A total of 307 DNA samples, extracted by the salt precipitation method, carrying 221 mutations and 21 polymorphisms, plus 20 control samples free from variations (confirmed by denaturing high-performance liquid chromatography analysis), was used. With the conditions described in this study, 100% of samples that carry heterozygous mutations and 60% of those with homozygous mutations were identified. The study of a cohort of 136 idiopathic chronic pancreatitis patients enabled us to prospectively evaluate this technique. Thus, high-resolution melting analysis is a robust and sensitive single-tube technique for screening mutations in a gene and promises to become the gold standard over denaturing high-performance liquid chromatography, particularly for highly mutated genes such as CFTR, and appears suitable for use in reference diagnostic laboratories.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687795      PMCID: PMC2518737          DOI: 10.2353/jmoldx.2008.080056

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  36 in total

1.  Mutation scanning of the RET protooncogene using high-resolution melting analysis.

Authors:  Rebecca L Margraf; Rong Mao; W Edward Highsmith; Leonard M Holtegaard; Carl T Wittwer
Journal:  Clin Chem       Date:  2006-01       Impact factor: 8.327

2.  A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model.

Authors:  Lan-Szu Chou; Elaine Lyon; Carl T Wittwer
Journal:  Am J Clin Pathol       Date:  2005-09       Impact factor: 2.493

3.  Distinguishing different DNA heterozygotes by high-resolution melting.

Authors:  Robert Graham; Michael Liew; Cindy Meadows; Elaine Lyon; Carl T Wittwer
Journal:  Clin Chem       Date:  2005-05-19       Impact factor: 8.327

4.  Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes.

Authors:  Mark G Herrmann; Jacob D Durtschi; L Kathryn Bromley; Carl T Wittwer; Karl V Voelkerding
Journal:  Clin Chem       Date:  2006-01-19       Impact factor: 8.327

5.  Instrument comparison for heterozygote scanning of single and double heterozygotes: a correction and extension of Herrmann et al., Clin Chem 2006;52:494-503.

Authors:  Mark G Herrmann; Jacob D Durtschi; L Kathryn Bromley; Carl T Wittwer; Karl V Voelkerding
Journal:  Clin Chem       Date:  2007-01       Impact factor: 8.327

6.  Simultaneous mutation scanning and genotyping by high-resolution DNA melting analysis.

Authors:  Jesse Montgomery; Carl T Wittwer; Robert Palais; Luming Zhou
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene.

Authors:  Steven F Dobrowolski; Jason T McKinney; Cristina Amat di San Filippo; Keow Giak Sim; Bridget Wilcken; Nicola Longo
Journal:  Hum Mutat       Date:  2005-03       Impact factor: 4.878

8.  Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis.

Authors:  Carlynn Willmore-Payne; Joseph A Holden; Barbara E Chadwick; Lester J Layfield
Journal:  Mod Pathol       Date:  2006-06-02       Impact factor: 7.842

9.  Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck.

Authors:  Carlynn Willmore-Payne; Joseph A Holden; Lester J Layfield
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

10.  Mutations in the phenylalanine hydroxylase gene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyping based upon thermal melt profiles.

Authors:  Steven F Dobrowolski; Clinton Ellingson; Thomas Coyne; Jesse Grey; Ranae Martin; Edwin W Naylor; Richard Koch; Harvey L Levy
Journal:  Mol Genet Metab       Date:  2007-05-14       Impact factor: 4.797

View more
  17 in total

1.  CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.

Authors:  Molly B Sheridan; Timothy W Hefferon; Nulang Wang; Christian Merlo; Carlos Milla; Drucy Borowitz; Eric D Green; Peter J Mogayzel; Garry R Cutting
Journal:  J Med Genet       Date:  2010-11-20       Impact factor: 6.318

2.  LightCycler technology in molecular diagnostics.

Authors:  Elaine Lyon; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2009-02-05       Impact factor: 5.568

3.  Minimal evidence for a direct involvement of twisted gastrulation homolog 1 (TWSG1) gene in human holoprosencephaly.

Authors:  Emily F Kauvar; Ping Hu; Daniel E Pineda-Alvarez; Benjamin D Solomon; Amalia Dutra; Evgenia Pak; Brooke Blessing; Virginia Proud; Alan L Shanske; Cathy A Stevens; Jill A Rosenfeld; Lisa G Shaffer; Erich Roessler; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2010-12-21       Impact factor: 4.797

4.  Alternative reliable method for cytochrome P450 2D6 poor metabolizers genotyping.

Authors:  E Pindurová; A Zourková; J Zrůstová; J Juřica; A Pavelka
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

5.  Mutation analysis of SLC26A4 for Pendred syndrome and nonsyndromic hearing loss by high-resolution melting.

Authors:  Neng Chen; Lisbeth Tranebjærg; Nanna Dahl Rendtorff; Iris Schrijver
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

6.  LNA Thymidine Monomer Enables Differentiation of the Four Single-Nucleotide Variants by Melting Temperature.

Authors:  Judy M Obliosca; Sara Y Cheng; Yu-An Chen; Mariana F Llanos; Yen-Liang Liu; Darren M Imphean; David R Bell; Jeffrey T Petty; Pengyu Ren; Hsin-Chih Yeh
Journal:  J Am Chem Soc       Date:  2017-05-09       Impact factor: 15.419

7.  Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile.

Authors:  Tsung-Chin Lin; Sin-Sien Jiang; Wen-Chien Chou; Hsin-An Hou; Yu-Min Lin; Chia-Ling Chang; Cherng-An Hsu; Hwei-Fang Tien; Liang-In Lin
Journal:  J Mol Diagn       Date:  2011-06-30       Impact factor: 5.568

8.  Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci.

Authors:  Sylvia Quemener; Jian-Min Chen; Nadia Chuzhanova; Caroline Bénech; Teresa Casals; Milan Macek; Thierry Bienvenu; Trudi McDevitt; Philip M Farrell; Ourida Loumi; Taieb Messaoud; Harry Cuppens; Garry R Cutting; Peter D Stenson; Karine Giteau; Marie-Pierre Audrézet; David N Cooper; Claude Férec
Journal:  Hum Mutat       Date:  2010-04       Impact factor: 4.878

9.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

10.  Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy.

Authors:  Marie Pierre Audrézet; Anne Munck; Virginie Scotet; Mireille Claustres; Michel Roussey; Dominique Delmas; Claude Férec; Marie Desgeorges
Journal:  Genet Med       Date:  2014-08-14       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.